Enrolling by invitationInterventional · Phase 3NCT04905693 ↗An Open-label Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease (TETON-OLE)
RecruitingInterventional · Phase 3NCT05943535 ↗A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)Anna PodolanczukPIInterventionDrug: Placebo · Drug: Inhaled Treprostinil · Device: Treprostinil Ultrasonic NebulizerDatesOct 2023 – Nov 2027 (est.)SponsorUnited TherapeuticsProgressive Pulmonary FibrosisInterstitial Lung Disease